Ayurvedic Product Launch Timeline: A Realistic Schedule
Most first launches run late for the same three reasons, and all three are predictable. Licensing, stability data and artwork approval consistently take longer than new brand owners plan for. Here is a realistic sequence and where the time actually goes.
Why Timelines Slip
This guide is for brand owners planning a first Ayurvedic, herbal or nutraceutical launch in India.
Production is usually the fastest part of the process and the part people plan around. The time actually goes into licensing, which depends on authority processing you do not control, stability data, which depends on elapsed time you cannot compress, and artwork approval, which depends on revision cycles people underestimate.
Because these three can run partly in parallel, sequencing matters as much as duration.
The Sequence
This order minimises dead time.
- Decide the regulatory route first: food and supplement framework, or Ayurvedic medicine. This determines everything downstream and cannot be changed cheaply later.
- Confirm your manufacturer’s licence actually covers your category and dosage form.
- Finalise the formulation against the permitted composition for your chosen route.
- Begin your own registration or licence application for selling, in parallel with formulation work.
- Make pilot batches and confirm the formulation performs in the intended pack.
- Start stability studies in the final pack. This is the hard constraint on launch date.
- Develop artwork while stability runs, allowing for several revision rounds and a compliance review.
- Order packaging components once artwork is approved, allowing for packaging lead time and MOQ.
- Agree the per-batch testing panel and documentation format.
- Run first production once licences, approved artwork and components are all in place.
- Review the launch file: licences, specification, stability, artwork approval, test reports.
Where the Time Goes
Understanding which steps are compressible helps you plan.
| Step | Compressible? | Notes |
|---|---|---|
| Regulatory route decision | Yes | A decision, not a process. Make it early. |
| Licence applications | No | Authority processing time is outside your control |
| Formulation development | Partly | Depends on complexity and clarity of brief |
| Pilot batches | Yes | Usually quick if the brief is clear |
| Stability studies | No | Elapsed time cannot be shortened |
| Artwork development | Yes | Compressible with a clear brief and early compliance review |
| Packaging procurement | Partly | Constrained by supplier lead time and MOQ |
| First production | Usually | Typically the shortest step in the whole sequence |
The two incompressible items, licensing and stability, should therefore start as early as possible and run alongside everything else.
Common Planning Mistakes
Each of these costs weeks.
Artwork Last
Designing artwork after stability completes serialises two steps that could run together, and compliance revisions then delay production.
Pack Changed Late
Switching container or closure after stability has started restarts the data. Decide the pack before stability, not after.
Licence Started Late
Beginning your own registration after production planning is the single most common cause of a stalled launch.
Optimistic Component Orders
Ordering printed packaging for optimistic volumes creates write-offs. Order against realistic first-year sales.
Launch Readiness Checklist
Confirm all of these before first production.
- Regulatory route decided and documented.
- Manufacturer licence verified for your category and dosage form.
- Your own registration or licence in place.
- Formulation finalised against permitted composition.
- Stability data generated in the final pack.
- Artwork approved and compliance-reviewed.
- Packaging components received and inspected.
- Per-batch testing panel agreed in writing.
- Claim set written and distributed to anyone who will sell.
- Documentation format for certificates of analysis agreed.
- Complete launch file assembled in one place.
Planning a Launch?
Share your product and target launch window and our team will map licensing, stability and production against a realistic schedule.
Frequently Asked Questions
What delays Ayurvedic product launches most?
Licensing, stability data and artwork approval. Production itself is usually the shortest step. The first two cannot be compressed, so they should start as early as possible and run alongside formulation and artwork work rather than after it.
Can stability studies be shortened?
No. Stability is a function of elapsed time in the final pack, and it is the hard constraint on your launch date. The practical response is to start it as early as possible and to avoid changing the pack afterwards, which restarts the data.
When should artwork development start?
While stability studies are running, not after. Artwork needs several revision rounds and a compliance review, and designing it late serialises two steps that could run in parallel, which is one of the most common causes of a delayed launch.
What decision has to come first?
The regulatory route: food and supplement framework, or Ayurvedic medicine. It determines permitted composition, licensing, labelling and claims, and changing it later is expensive. Make it before formulation work begins.
How much packaging should I order for a first launch?
Against realistic first-year sales rather than optimistic projections, while respecting the supplier’s minimum. Printed components cannot be reused across SKUs, so obsolete packaging is one of the most common early write-offs for new brands.